National Immunisation Schedules
Different countries and regions may be affected by different diseases. In some cases, countries may also be affected by a different strain of the same disease. Thus , the National Immunisation Schedule may differ from one country to the next. Each country will design and implement their National Immunisation Program(NIP) based on the World Health Organisation(WHO) Expanded Programme on Immunisation(EPI) and guidelines.
If you like to know more about the mandatory vaccines in the NIPs of the countries we are present in, please select from below.
| Age | Vaccine |
| Birth | Baccillus Calmette- Guerin (BCG), 1st dose: Hepatitis B (HepB) |
| 1 month | 2nd dose: Hepatitis B |
| 2 months | 1st dose: Diptheria, Tetanus, acellular Pertussis (DTaP), Haemophilus influenza b (Hib), Inactivated Poliovirus (IPV) |
| 3 months | 2nd dose: DTaP, Hib, IPV |
| 5 months | 3rd Dose: DTP, Hib, IPV |
| 6 months | 3rd dose: Hepatitis B, Measles (Sabah Only) |
| 10 months | 1st dose: Japanese Encephalitis (JE) (Sarawak Only) |
| 12 months | 1st dose: Mumps, Measles, Rubella (MMR), 2nd dose: Japanese Encephalitis (Sarawak Only) |
| 18 months | 4th dose: DTP, Hib, IPV, 3rd dose: JE (Sarawak Only) |
| 4 years old | 4th dose: JE ( Sarawak Only) |
| 7 years old | BCG (option only if no scar found), Diphtheria, Tetanus (DT booster), 2nd dose of MMR |
| 13 years old | Human papillomavirus (HPV) with 3 doses within 6 months |
| 15 years old | Tetanus (TT) |
Ministry of Health Malaysia 2016
Table 1. Current national immunization program of Iran (Sep 2012)
| Vaccine | Schedule |
| BCG | birth |
| OPV | Birth; 2,4,6,18 mo and 6 y |
| HepB | Birth;2 and 6 mo; specified high risk groups |
| DTwP | 2,4,6,18 mos and 6 y |
| MMR | 12 and 18 mo |
| MenAC | Military Personnel |
| Rubella | Women of child- bearing age with negative test for rubella |
| Td | Repeated every 10 y- for military and pregnant women |
| Varicella | Parts of country (high-risk groups) |
| Influenza | Specified high- risk groups |
Ref: Moradi-Lakeh M., & Esteghamati A. (2013). National Immunization Program in Iran. Whys and why nots, Human Vaccines & Immunotherapeutics, 9(1), pp. 112-114.
Schedule of Essential Vaccination by Age, State of Kuwait. 2008
| Age of Vaccination | Vaccine Type | Route of Administration |
| Pregnant mother | – 2 doses of tetanus Toxoid in 5th & 7th month of 1st Pregnancy (0.5ml)
– One dose for TT for each next pregnancy (0.5ml) |
– I.M in deltoid muscle |
| 2nd day of child birth | – 1st Dose of Hepatitis B (HBV) | – I.M Upper middle or mid anterior of thigh |
| End of 2nd month of age | – 1st Dose of IPV (SALK) (0.5ml)
– 1st Dose of Pentavalent (DPT Hib HBV) (0.5ml) – 1st Dose of Pneumococcal (PCV13)(0.5ml) |
– I.M Upper middle or mid anterior of thigh
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| End of 3rd month | – BCG vaccine | – Intradermal in the Upper lateral part of left arm |
| End of 4th month of age | – 1st dose of OPV (Type 1,2,3)
– 2nd Dose of Pentavalent – 2nd Dose of Pneumococcal |
– 2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| End of 6th month of age | – 2nd ose of OPV (Type 1,2,3)
– 3rd Dose of Pentavalent – 3rd Dose of Pneumococcal
|
– -2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| 1st year of age | – MMR Vaccine (0.5ml)
– 3rd Dose of OPV (type 1,2, 3) |
– S.C in the arm
– 2 drops Oral Sabin |
| 18th month of age | – 4th Dose of OPV (type 1,2,3)
– Booster Dose of Pentavalent – Booster Dose of MMR (0.5ml) |
– 2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| 2 year old | – Meningococcal meningitis (ACWY)
– Booster Dose of DPT (0.5ml) |
– S.C in the arm (0.5ml)
– I.M in deltoid muscle |
| 3.5 years old | – Booster Dose of OPV (Type 1,2,3)
– – Booster Dose of DPT (0.5ml) |
– 2 drops Oral Sabin
– I.M |
| 10-12 years old | – Booster Dose of MMR (Females)
– – Td (Tetanus+ Diphtheria) (0.5ml) |
– S.C in the arm
– I.M in deltoid muscle |
| 16-18 years old | – Td (Tetanus+ Diphtheria) ( 0.5ml) | – I.M in deltoid muscle |
(According to Ministerial Circular No 75/2008)
Kingdom of Bahrain
Recommended Immunisation Schedule
Ref: Bahrain MOH (2017) Available at: https://www.moh.gov.bh/HealthInfo/Immunizations?lang=en (Accessed: 29 Nov 2017)
National Immunisation Program
| Age Vaccine | Birth | 2 Mos | 4 Mos | 6 Mos | 12 Mos | 18 Mos | 5-6 Years |
| BCG | BCG | ||||||
| Diphtheria, Pertusis, Tetanus | Dtap | Dtap | Dtap | Dtap | DPT | ||
| Haemophilus Influenza Type b | Hib | Hib | Hib | Hib | |||
| Hep. B | HBV | HBV | HBV | HBV | |||
| Polio | IPV | OPV | OPV | OPV | OPV | ||
| Pneumococcal | PCV | PCV | PCV | PCV | |||
| Measles, Mumps, Rubella | MMR | MMR | |||||
| Varicella | Varicella | Varicella |
Combined Dose Single Dose
Ref: Health Authority (Dubai) (n.d.) Available at: https://www.dha.gov.ae/Documents/HRD/Immunization%20Guidelines.pdf (Accessed: 29 Nov 2017).
Department of Communicable Disease Surveillance & Control
Directorate General of Health Affairs, Ministry of Health
Immunization Schedule- w.e.f. January 2012
| Age of vaccination | Schedule |
| At birth | BCG
HBV |
| 2 months | Penta- 1 (HBV, DTP, Hib)
PCV- 1 |
| 9 weeks | IPV |
| 4 months | Penta-2 (HBV, DTP, Hib)
OPV-1 PCV-2 |
| 6 months | PENTA-3 (HBV,DTP, Hib) OPV-2 |
| 9 months | Vitamin A 100,00 IU |
| 12 months | MMR-1,
Vericella |
| 13 months | PCV Booster |
| 18 months | MMR-2 DTP Booster OPV Booster Vitamin A 200,00 IU |
Oman MOH (2012). Immunization Schedule. Available at: http://www.nitag-resource.org/uploads/media/default/0001/01/b9284bf7d0baa927711c7b0a30af8f5d3d7e537d.jpeg (Accessed: 2017).
Immunization Schedule in the State of Qatar- 2016
| Age | Birth | 2 months | 4 months | 6 months | 12 months | 15 months | 18 months | 2 years | 4-6 years | 13-16 years |
| Vaccine | ||||||||||
| BCG | BCG | |||||||||
| HEPATITIS B | Hepatitis B | |||||||||
| PENTA | Penta | |||||||||
| HEXA | Hexa 1 | Hexa 2 | ||||||||
| TETRA | Tetra | |||||||||
| DTAP | DTaP Booster | |||||||||
| TDAP | Tdap | |||||||||
| ROTAVIRUS | Rota 1 | Rota 2 | ||||||||
| OPV | OPV 1 | OPV 2 | OPV (Booster) | OPV (Booster) | ||||||
| PVC 13 | PCV 1 | PCV 2 | PCV 3 | PCV (Booster) | ||||||
| MMR | MMR1 | MMR 2 | ||||||||
| VARICELLA | Vericella 1 | |||||||||
| HEPATITIS A | Hep A 1 | Hep A 2 | ||||||||
| INFLUENZA | Influenza | |||||||||
| MENINGOCOCCAL ACYW 135 | Meningococcal | |||||||||
MOH Qatar (2016). Available at: https://www.moph.gov.qa/app/media/4052 (Accessed: 29 Nov 2017).
National Childhood Immunisation Schedule, Singapore
| Vaccination against | Birth | 1 month | 3 months | 4 months | 5 months | 6 months | 12 months | 15 months | 18 months | 6-7 years | 10-11 years |
| Tuberculosis | BCG | ||||||||||
| Hepatitis B | HepB (D1) | HepB (D2) | HepB (D3)# | ||||||||
| Diphtheria, Tetanus, Pertussis | DTaP
(D1) |
DTaP
(D2) |
DTaP
(D3) |
DTaP
(B1) |
Tdap (B2) | ||||||
| Poliovirus | IPV (D1) | IPV (D2) | IPV (D3) | IPV (B1) | OPV (B2) | ||||||
| Haemophilus influenza type b | Hib (D1) | Hib (D2) | Hib (D3) | Hib (B1) | |||||||
| Measles, Mumps, Rubella | MMR (D1) | MMR (D2)# | |||||||||
| Pneumococcal Disease | PCV
(D1) |
PCV
(D2) |
PCV (B1) | ||||||||
| Human Papilomavirus | Recommended for females 9 to 26 years: three doses are required at interval of 0,2,6 months | ||||||||||
Ref: Singapore MOH (2013). National Childhood Immunisation Schedule, Singapore. Available at: https://www.moh.gov.sg/content/dam/moh_web/Diseases%20and%20Conditions/Influenza/NCIS%201%20June%202013.pdf (Accessed: 29 Nov 2017).
Table 2: Immunization schedule, 2015
| Vaccine | Age of Administration |
| HepB | 0 to 7 days of birth |
| BCG | 1 month |
| OPV | 1 month, 2months, 3 months, 4 months |
| DTP-Hib- HepB | 2 months, 3 months, 4 months, 18 months |
| Measles | 9 months, 24 months |
| DT | 6-7 years |
| Td | 7-8 years, 8-9 years |
| TT
Vitamin A |
Females 15 to 39
6- 59 months |
Ref: WHO (2016). Indonesia. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/indonesia.pdf (Accessed: 29 Nov 2017).
Table 2: Immunization schedule, 2015
| Vaccine | Age of administration |
| BCG | At birth |
| DTP- Hib- HepB | 6 weeks, 10 weeks, 14 weeks |
| OPV | 6 weeks, 10 weeks, 14 weeks, 38 weeks |
| PCV | 6 weeks, 10 weeks, 18 weeks |
| IPV | 14 weeks |
| MR | 38 weeks, 15 months |
| Measles | 15 months |
| TT | Females 15-49 (5 doses with an interval of +1 month, +6 months, +1 year and +1 year with preceding dose) |
Ref: WHO (2016). Bangladesh. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/bangladesh.pdf (Accessed: 29 Nov 2017).
| Vaccine | Age |
| BCG | Birth- 2 months |
| DTwP- Hib- HepB | 2,4,6 months |
| IPV | 4 months |
| MR | 9 months |
| Measles | 18 months |
| OPV | 2, 4, 6 months |
| TT | 1st contact pregnancy, +4weeks |
Myanmar immunization schedule (WHO, 2016)
Table 2: Immunization schedule, 2015
| Vaccine | Age of Administration |
| BCG | At birth |
| HepB | At birth, 1 month (new- born from HepB carrier mother) |
| DTP- HepB | 2 months, 4 months, 6 months |
| OPV | 2 months, 4 months, 6 months, 1.5 years, 4 years |
| MMR | 9 months, 2.5 years |
| DTP | 1.5 years, 4 years |
| Td | School children in grade VI (12 years) and pregnant women at 1st contact, +1 month, +6 month (depending on vaccination history) |
| JE_ Inactd | 1 years (2 doses 4 week apart), 2.5 years |
| JE_LiveAtd | 1 years, 2.5 years (sub-national) |
Ref: WHO (2016). Thailand. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/thailand.pdf (Accessed: 29 Nov 2017).
| Vaccine | Age |
| BCG | birth |
| Cholera | 2 doses at 2-5 years of age* |
| DTwP | 18 months |
| DTwP-Hib-HepB | 2, 3, 4 months |
| HepB- Pediatric | Birth |
| JapEnc | 12 month; + 2 weeks; 2 years |
| MR | 18 months |
| Measles | 9, 18 months |
| OPV | 2,3,4 months |
| TT | Pregnant women,+1, +6 months: +1 year |
| Typhoid | 3 years* |
*In specific geographical areas
Vietnam immunization schedule (WHO, 2016)
The current immunization schedule for Cambodia’s National Immunization Program (NIP) includes BCG, DPT- HepB- Hin, TT, monovalent HepB, OPV, measles and Japanese Encephalitis ( live attenuated vaccine). GAVI supports the funding for IPV, JEV, Measles, Measles- Rubella, Penta, Pneumo and Tetra DTP_ HepB vaccines in Cambodia.
| Vaccine | Age of Administration | Comments |
| BCG | Birth | |
| DPT- HepB- Hib | 6wk, 10wk, 14wk | Pentavalent vaccine introduced in 2010. |
| TT | First contact pregnancy, +M1, +M6, +Y1, +Y1. | A total of five doses are being recommended for CBAW. |
| Monovalent HepB | At birth | A policy of within 24 hours is promoted in line with recommendation of WHO, though
Provided upto 7 days of age if the infant cannot be contacted within 24 hours of birth |
| Polio (OPV) | 6wk, 10wk, 14wk | |
| Measles | 9-11 months | A second opportunity to measles vaccination is provided through periodically scheduled campaigns, and a routine 2nd dose is planned from 2012. |
| Japanese Encephalitis (live attenuated vaccine) | 12 months, +1 year | Planned from 2010 in three provinces, provided resources can be mobilized and vaccine can be procured given lack of WHO prequalification as of now |
Ref: Cambodia MOH (2011). CAMBODIA National Immunization Program Strategic Plan 2008 – 2015. Available at: https://www.medbox.org/countries/cambodia-national-immunization-program-strategic-plan-2008-2015/preview? (Accessed: 29 Nov 2017).
| Vaccine | Age |
| BCG | Birth |
| DTwP- Hib- HepB | 6, 10, 14 weeks |
| HPV | 1st contact, +6months* |
| HepB- Pediatric | Birth |
| IPV | 14 weeks |
| MMR | 12 months |
| MR | 6 years |
| Measles | 9 months |
| OPV | 6, 10, 14 weeks |
| PCV | 6, 10, 14 weeks* |
| Rotavirus | 6-15, 32 weeks* |
| TT | 1st contact during 1st trimester, +1 month |
| Td | 6,10 years |
*In specific geographical areas
Philippine national immunization schedule (WHO, 2016)
Vaccinations for childhood TB, polio, diphtheria, tetanus, pertussis, HepB, Hib pneumonia and meningitis, pneumonia and meningitis due to s. pneumoniae, and measles are included in Pakistan’s expanded program on immunization (EPI). GAVI supports the funding for HepB mono, IPV, Measles SIA, Penta, Pneumo and Tetra DTP-HepB vaccines.
Immunization schedule for infants:
| Age | Vaccine |
| At Birth | BCG, OPVO |
| 6 weeks | Pentavalent 1, OPV1 |
| 10 weeks | Pentavalent 2, OPV2 |
| 14 weeks | Pentavalent 3, OPV3 |
| 9 months | Measles 1 |
| At 2nd year of life | Measles 2 |
Immunization schedule for pregnant women and women of childbearing age (15-49 years):
| Dose | When to give | Expected duration of protection |
| TT1 | At first contact or as early as possible during pregnancy | None |
| TT2 | At least 4 weeks after TT1 | 1-3 years |
| TT3 | At least 6 months after TT2 | 5 years |
| TT4 | At least 1 year after TT3 | 10 years |
| TT5 | At least 1 year after TT4 | Throughout the childbearing age |
Ref: Pakistan MNHSR&C (Ministry of National Health Services Regulations and Coordination (n.d.). Available at: http://epi.gov.pk/?page_id=139 (Accessed: 29 Nov 2017).
| Age | Vaccine |
| At Birth | BCG, Hep B |
| 2 months | IPV, DTaP, Hepatities B, Hib, PCV13, Rota |
| 4 months | IPV, DTaP, Hepatities B, Hib, PCV13, Rota |
| 6 months | OPV, IPV, DTaP, Hepatities B, Hib, PCV13 |
| 9 months | Measles and Meningococcal Conjugate Quadrivalent (MCV4) |
| 12 months | OPV, MMR, PCV13, Meningococcal Conjugate Quadrivalent (MCV4) |
| 18 months | OPV, DTaP, Hib, MMR, Varicella, Hepatities A |
| 24 months | Hepatities A |
| Primary school | OPV, DTap, MMR, Varicella |
MALAYSIA
| Age | Vaccine |
| Birth | Baccillus Calmette- Guerin (BCG), 1st dose: Hepatitis B (HepB) |
| 1 month | 2nd dose: Hepatitis B |
| 2 months | 1st dose: Diptheria, Tetanus, acellular Pertussis (DTaP), Haemophilus influenza b (Hib), Inactivated Poliovirus (IPV) |
| 3 months | 2nd dose: DTaP, Hib, IPV |
| 5 months | 3rd Dose: DTP, Hib, IPV |
| 6 months | 3rd dose: Hepatitis B, Measles (Sabah Only) |
| 10 months | 1st dose: Japanese Encephalitis (JE) (Sarawak Only) |
| 12 months | 1st dose: Mumps, Measles, Rubella (MMR), 2nd dose: Japanese Encephalitis (Sarawak Only) |
| 18 months | 4th dose: DTP, Hib, IPV, 3rd dose: JE (Sarawak Only) |
| 4 years old | 4th dose: JE ( Sarawak Only) |
| 7 years old | BCG (option only if no scar found), Diphtheria, Tetanus (DT booster), 2nd dose of MMR |
| 13 years old | Human papillomavirus (HPV) with 3 doses within 6 months |
| 15 years old | Tetanus (TT) |
Ministry of Health Malaysia 2016
IRAN
Table 1. Current national immunization program of Iran (Sep 2012)
| Vaccine | Schedule |
| BCG | birth |
| OPV | Birth; 2,4,6,18 mo and 6 y |
| HepB | Birth;2 and 6 mo; specified high risk groups |
| DTwP | 2,4,6,18 mos and 6 y |
| MMR | 12 and 18 mo |
| MenAC | Military Personnel |
| Rubella | Women of child- bearing age with negative test for rubella |
| Td | Repeated every 10 y- for military and pregnant women |
| Varicella | Parts of country (high-risk groups) |
| Influenza | Specified high- risk groups |
Ref: Moradi-Lakeh M., & Esteghamati A. (2013). National Immunization Program in Iran. Whys and why nots, Human Vaccines & Immunotherapeutics, 9(1), pp. 112-114.
KUWAIT
Schedule of Essential Vaccination by Age, State of Kuwait. 2008
| Age of Vaccination | Vaccine Type | Route of Administration |
| Pregnant mother | – 2 doses of tetanus Toxoid in 5th & 7th month of 1st Pregnancy (0.5ml)
– One dose for TT for each next pregnancy (0.5ml) |
– I.M in deltoid muscle |
| 2nd day of child birth | – 1st Dose of Hepatitis B (HBV) | – I.M Upper middle or mid anterior of thigh |
| End of 2nd month of age | – 1st Dose of IPV (SALK) (0.5ml)
– 1st Dose of Pentavalent (DPT Hib HBV) (0.5ml) – 1st Dose of Pneumococcal (PCV13)(0.5ml) |
– I.M Upper middle or mid anterior of thigh
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| End of 3rd month | – BCG vaccine | – Intradermal in the Upper lateral part of left arm |
| End of 4th month of age | – 1st dose of OPV (Type 1,2,3)
– 2nd Dose of Pentavalent – 2nd Dose of Pneumococcal |
– 2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| End of 6th month of age | – 2nd ose of OPV (Type 1,2,3)
– 3rd Dose of Pentavalent – 3rd Dose of Pneumococcal
|
– -2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| 1st year of age | – MMR Vaccine (0.5ml)
– 3rd Dose of OPV (type 1,2, 3) |
– S.C in the arm
– 2 drops Oral Sabin |
| 18th month of age | – 4th Dose of OPV (type 1,2,3)
– Booster Dose of Pentavalent – Booster Dose of MMR (0.5ml) |
– 2 drops Oral Sabin
– I.M Upper middle or mid anterior of thigh – I.M Upper middle or mid anterior of other thigh |
| 2 year old | – Meningococcal meningitis (ACWY)
– Booster Dose of DPT (0.5ml) |
– S.C in the arm (0.5ml)
– I.M in deltoid muscle |
| 3.5 years old | – Booster Dose of OPV (Type 1,2,3)
– – Booster Dose of DPT (0.5ml) |
– 2 drops Oral Sabin
– I.M |
| 10-12 years old | – Booster Dose of MMR (Females)
– – Td (Tetanus+ Diphtheria) (0.5ml) |
– S.C in the arm
– I.M in deltoid muscle |
| 16-18 years old | – Td (Tetanus+ Diphtheria) ( 0.5ml) | – I.M in deltoid muscle |
(According to Ministerial Circular No 75/2008)
BAHRAIN
Kingdom of Bahrain
Recommended Immunisation Schedule
Ref: Bahrain MOH (2017) Available at: https://www.moh.gov.bh/HealthInfo/Immunizations?lang=en (Accessed: 29 Nov 2017)
UNITED ARAB EMIRATES
National Immunisation Program
| Age Vaccine | Birth | 2 Mos | 4 Mos | 6 Mos | 12 Mos | 18 Mos | 5-6 Years |
| BCG | BCG | ||||||
| Diphtheria, Pertusis, Tetanus | Dtap | Dtap | Dtap | Dtap | DPT | ||
| Haemophilus Influenza Type b | Hib | Hib | Hib | Hib | |||
| Hep. B | HBV | HBV | HBV | HBV | |||
| Polio | IPV | OPV | OPV | OPV | OPV | ||
| Pneumococcal | PCV | PCV | PCV | PCV | |||
| Measles, Mumps, Rubella | MMR | MMR | |||||
| Varicella | Varicella | Varicella |
Combined Dose Single Dose
Ref: Health Authority (Dubai) (n.d.) Available at: https://www.dha.gov.ae/Documents/HRD/Immunization%20Guidelines.pdf (Accessed: 29 Nov 2017).
OMAN
Department of Communicable Disease Surveillance & Control
Directorate General of Health Affairs, Ministry of Health
Immunization Schedule- w.e.f. January 2012
| Age of vaccination | Schedule |
| At birth | BCG
HBV |
| 2 months | Penta- 1 (HBV, DTP, Hib)
PCV- 1 |
| 9 weeks | IPV |
| 4 months | Penta-2 (HBV, DTP, Hib)
OPV-1 PCV-2 |
| 6 months | PENTA-3 (HBV,DTP, Hib) OPV-2 |
| 9 months | Vitamin A 100,00 IU |
| 12 months | MMR-1,
Vericella |
| 13 months | PCV Booster |
| 18 months | MMR-2 DTP Booster OPV Booster Vitamin A 200,00 IU |
Oman MOH (2012). Immunization Schedule. Available at: http://www.nitag-resource.org/uploads/media/default/0001/01/b9284bf7d0baa927711c7b0a30af8f5d3d7e537d.jpeg (Accessed: 2017).
QATAR
Immunization Schedule in the State of Qatar- 2016
| Age | Birth | 2 months | 4 months | 6 months | 12 months | 15 months | 18 months | 2 years | 4-6 years | 13-16 years |
| Vaccine | ||||||||||
| BCG | BCG | |||||||||
| HEPATITIS B | Hepatitis B | |||||||||
| PENTA | Penta | |||||||||
| HEXA | Hexa 1 | Hexa 2 | ||||||||
| TETRA | Tetra | |||||||||
| DTAP | DTaP Booster | |||||||||
| TDAP | Tdap | |||||||||
| ROTAVIRUS | Rota 1 | Rota 2 | ||||||||
| OPV | OPV 1 | OPV 2 | OPV (Booster) | OPV (Booster) | ||||||
| PVC 13 | PCV 1 | PCV 2 | PCV 3 | PCV (Booster) | ||||||
| MMR | MMR1 | MMR 2 | ||||||||
| VARICELLA | Vericella 1 | |||||||||
| HEPATITIS A | Hep A 1 | Hep A 2 | ||||||||
| INFLUENZA | Influenza | |||||||||
| MENINGOCOCCAL ACYW 135 | Meningococcal | |||||||||
MOH Qatar (2016). Available at: https://www.moph.gov.qa/app/media/4052 (Accessed: 29 Nov 2017).
SINGAPORE
National Childhood Immunisation Schedule, Singapore
| Vaccination against | Birth | 1 month | 3 months | 4 months | 5 months | 6 months | 12 months | 15 months | 18 months | 6-7 years | 10-11 years |
| Tuberculosis | BCG | ||||||||||
| Hepatitis B | HepB (D1) | HepB (D2) | HepB (D3)# | ||||||||
| Diphtheria, Tetanus, Pertussis | DTaP
(D1) |
DTaP
(D2) |
DTaP
(D3) |
DTaP
(B1) |
Tdap (B2) | ||||||
| Poliovirus | IPV (D1) | IPV (D2) | IPV (D3) | IPV (B1) | OPV (B2) | ||||||
| Haemophilus influenza type b | Hib (D1) | Hib (D2) | Hib (D3) | Hib (B1) | |||||||
| Measles, Mumps, Rubella | MMR (D1) | MMR (D2)# | |||||||||
| Pneumococcal Disease | PCV
(D1) |
PCV
(D2) |
PCV (B1) | ||||||||
| Human Papilomavirus | Recommended for females 9 to 26 years: three doses are required at interval of 0,2,6 months | ||||||||||
Ref: Singapore MOH (2013). National Childhood Immunisation Schedule, Singapore. Available at: https://www.moh.gov.sg/content/dam/moh_web/Diseases%20and%20Conditions/Influenza/NCIS%201%20June%202013.pdf (Accessed: 29 Nov 2017).
INDONESIA
Table 2: Immunization schedule, 2015
| Vaccine | Age of Administration |
| HepB | 0 to 7 days of birth |
| BCG | 1 month |
| OPV | 1 month, 2months, 3 months, 4 months |
| DTP-Hib- HepB | 2 months, 3 months, 4 months, 18 months |
| Measles | 9 months, 24 months |
| DT | 6-7 years |
| Td | 7-8 years, 8-9 years |
| TT
Vitamin A |
Females 15 to 39
6- 59 months |
Ref: WHO (2016). Indonesia. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/indonesia.pdf (Accessed: 29 Nov 2017).
BANGLADESH
Table 2: Immunization schedule, 2015
| Vaccine | Age of administration |
| BCG | At birth |
| DTP- Hib- HepB | 6 weeks, 10 weeks, 14 weeks |
| OPV | 6 weeks, 10 weeks, 14 weeks, 38 weeks |
| PCV | 6 weeks, 10 weeks, 18 weeks |
| IPV | 14 weeks |
| MR | 38 weeks, 15 months |
| Measles | 15 months |
| TT | Females 15-49 (5 doses with an interval of +1 month, +6 months, +1 year and +1 year with preceding dose) |
Ref: WHO (2016). Bangladesh. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/bangladesh.pdf (Accessed: 29 Nov 2017).
MYANMAR
| Vaccine | Age |
| BCG | Birth- 2 months |
| DTwP- Hib- HepB | 2,4,6 months |
| IPV | 4 months |
| MR | 9 months |
| Measles | 18 months |
| OPV | 2, 4, 6 months |
| TT | 1st contact pregnancy, +4weeks |
Myanmar immunization schedule (WHO, 2016)
THAILAND
Table 2: Immunization schedule, 2015
| Vaccine | Age of Administration |
| BCG | At birth |
| HepB | At birth, 1 month (new- born from HepB carrier mother) |
| DTP- HepB | 2 months, 4 months, 6 months |
| OPV | 2 months, 4 months, 6 months, 1.5 years, 4 years |
| MMR | 9 months, 2.5 years |
| DTP | 1.5 years, 4 years |
| Td | School children in grade VI (12 years) and pregnant women at 1st contact, +1 month, +6 month (depending on vaccination history) |
| JE_ Inactd | 1 years (2 doses 4 week apart), 2.5 years |
| JE_LiveAtd | 1 years, 2.5 years (sub-national) |
Ref: WHO (2016). Thailand. Expanded Immunisation Fact Sheet: Immunization Schedule, 2015. Available at: http://www.searo.who.int/entity/immunization/data/thailand.pdf (Accessed: 29 Nov 2017).
VIETNAM
| Vaccine | Age |
| BCG | birth |
| Cholera | 2 doses at 2-5 years of age* |
| DTwP | 18 months |
| DTwP-Hib-HepB | 2, 3, 4 months |
| HepB- Pediatric | Birth |
| JapEnc | 12 month; + 2 weeks; 2 years |
| MR | 18 months |
| Measles | 9, 18 months |
| OPV | 2,3,4 months |
| TT | Pregnant women,+1, +6 months: +1 year |
| Typhoid | 3 years* |
*In specific geographical areas
Vietnam immunization schedule (WHO, 2016)
CAMBODIA
The current immunization schedule for Cambodia’s National Immunization Program (NIP) includes BCG, DPT- HepB- Hin, TT, monovalent HepB, OPV, measles and Japanese Encephalitis ( live attenuated vaccine). GAVI supports the funding for IPV, JEV, Measles, Measles- Rubella, Penta, Pneumo and Tetra DTP_ HepB vaccines in Cambodia.
| Vaccine | Age of Administration | Comments |
| BCG | Birth | |
| DPT- HepB- Hib | 6wk, 10wk, 14wk | Pentavalent vaccine introduced in 2010. |
| TT | First contact pregnancy, +M1, +M6, +Y1, +Y1. | A total of five doses are being recommended for CBAW. |
| Monovalent HepB | At birth | A policy of within 24 hours is promoted in line with recommendation of WHO, though
Provided upto 7 days of age if the infant cannot be contacted within 24 hours of birth |
| Polio (OPV) | 6wk, 10wk, 14wk | |
| Measles | 9-11 months | A second opportunity to measles vaccination is provided through periodically scheduled campaigns, and a routine 2nd dose is planned from 2012. |
| Japanese Encephalitis (live attenuated vaccine) | 12 months, +1 year | Planned from 2010 in three provinces, provided resources can be mobilized and vaccine can be procured given lack of WHO prequalification as of now |
Ref: Cambodia MOH (2011). CAMBODIA National Immunization Program Strategic Plan 2008 – 2015. Available at: https://www.medbox.org/countries/cambodia-national-immunization-program-strategic-plan-2008-2015/preview? (Accessed: 29 Nov 2017).
PHILIPPINES
| Vaccine | Age |
| BCG | Birth |
| DTwP- Hib- HepB | 6, 10, 14 weeks |
| HPV | 1st contact, +6months* |
| HepB- Pediatric | Birth |
| IPV | 14 weeks |
| MMR | 12 months |
| MR | 6 years |
| Measles | 9 months |
| OPV | 6, 10, 14 weeks |
| PCV | 6, 10, 14 weeks* |
| Rotavirus | 6-15, 32 weeks* |
| TT | 1st contact during 1st trimester, +1 month |
| Td | 6,10 years |
*In specific geographical areas
Philippine national immunization schedule (WHO, 2016)
PAKISTAN
Vaccinations for childhood TB, polio, diphtheria, tetanus, pertussis, HepB, Hib pneumonia and meningitis, pneumonia and meningitis due to s. pneumoniae, and measles are included in Pakistan’s expanded program on immunization (EPI). GAVI supports the funding for HepB mono, IPV, Measles SIA, Penta, Pneumo and Tetra DTP-HepB vaccines.
Immunization schedule for infants:
| Age | Vaccine |
| At Birth | BCG, OPVO |
| 6 weeks | Pentavalent 1, OPV1 |
| 10 weeks | Pentavalent 2, OPV2 |
| 14 weeks | Pentavalent 3, OPV3 |
| 9 months | Measles 1 |
| At 2nd year of life | Measles 2 |
Immunization schedule for pregnant women and women of childbearing age (15-49 years):
| Dose | When to give | Expected duration of protection |
| TT1 | At first contact or as early as possible during pregnancy | None |
| TT2 | At least 4 weeks after TT1 | 1-3 years |
| TT3 | At least 6 months after TT2 | 5 years |
| TT4 | At least 1 year after TT3 | 10 years |
| TT5 | At least 1 year after TT4 | Throughout the childbearing age |
Ref: Pakistan MNHSR&C (Ministry of National Health Services Regulations and Coordination (n.d.). Available at: http://epi.gov.pk/?page_id=139 (Accessed: 29 Nov 2017).
SAUDI ARABIA
| Age | Vaccine |
| At Birth | BCG, Hep B |
| 2 months | IPV, DTaP, Hepatities B, Hib, PCV13, Rota |
| 4 months | IPV, DTaP, Hepatities B, Hib, PCV13, Rota |
| 6 months | OPV, IPV, DTaP, Hepatities B, Hib, PCV13 |
| 9 months | Measles and Meningococcal Conjugate Quadrivalent (MCV4) |
| 12 months | OPV, MMR, PCV13, Meningococcal Conjugate Quadrivalent (MCV4) |
| 18 months | OPV, DTaP, Hib, MMR, Varicella, Hepatities A |
| 24 months | Hepatities A |
| Primary school | OPV, DTap, MMR, Varicella |
